Amitriptyline or not, that is the question: pharmacogenetic testing of CYP2D6 and CYP2C19 identifies patients with low or high risk for side effects in amitriptyline therapy - Steimer, W; Zopf, K; von Amelunxen, S (Clin Chem, 2005)
et al.